Capturing biological complexity to empower biomarker discovery
ON-DEMAND By Takara Bio
Sign up for this free webinar and discover how refined cell atlases can provide comprehensive roadmaps for health and disease.
List view / Grid view
Webinars
Leveraging innovative strategies for speedy cell line development
ON-DEMAND By Sartorius
Join this roundtable of industry experts as they discuss technologies, best practices and strategies for delivering robust, stable, high-yielding cell lines to accelerate and streamline the drug discovery process.
Cardiac proarrhythmic risk assessment using human-induced pluripotent stem cell-derived cardiomyocytes
ON-DEMAND By Eurofins Discovery
Watch this on-demand webinar that discusses the two assays developed by Eurofins and why they represent a more physiologic and dynamic system to provide a more comprehensive pre-clinical model for cardiac liability assessment.
Accelerating drug discovery using novel screening technologies
ON-DEMAND By 10X Genomics
Explore the latest developments in screening technologies and how drug discovery has changed during the past decades in our webinar with 10X Genomics.
Utilising synthetic DNA technologies for high-throughput antibody discovery and optimisation
ON-DEMAND By Sartorius AG
In this on-demand webinar, our expert illustrates the utility of GPCR libraries and explains how to discover potent functional antibodies against multiple GPCR targets.
The promise of therapeutic nanobodies
ON-DEMAND By Bio-Techne
Watch this on-demand webinar and learn about robust technologies for nanobody drug discovery.
Scalable solutions for automated sample preparation in label-free compound profiling
ON-DEMAND By Analytik Jena
In this on-demand webinar, based on field experiences with our research partners, Analytik Jena provides an overview of application demands for a reliable sample preparation automation – from a small and easy-to-use workstation, to a fully automated integration solution by Analytik Jena.
Automating functional cell-based bioassays: assay reproducibility and performance for potency testing programmes
ON-DEMAND By Eurofins DiscoverX* and Tecan
In this on-demand webinar, we discuss how Eurofins DiscoverX’s off-the-shelf, MOA-based functional, cellular assays address these challenges, enabling drug discovery programmes up to late-stage development and market release.
Advantages of including untargeted and targeted metabolomics into drug development and clinical trials
ON-DEMAND By Metabolon
Discover how metabolomics can support your biomarker strategy in drug development and clinical trials in this on-demand webinar.
Cellular Thermal Shift Assays – bringing relevant target engagement to your drug discovery workflow
ON-DEMAND By PerkinElmer
Get the Big Picture and listen to Pharma thought leaders how they view CETSA® and its impact on their Drug Discovery.
Hit discovery for GPCRs: HTS or virtual screens?
ON-DEMAND By Beacon Discovery
Watch our on-demand webinar and learn from an industry expert regarding GPCR virtual screening approaches and challenges and much more.
Imaging Mass Cytometry™ of malignant tissue architecture: rare single cells to structured multi-cellular communities
ON-DEMAND By Fluidigm
Watch our free on-demand webinar to learn more about using Imaging Mass Cytometry™ (IMC™) to measure over 40 protein targets with subcellular resolution.
Realise the true power of your online, atline and offline biologics data
ON-DEMAND By IDBS
Register today for our on-demand upcoming webinar and discover more on about Polar High-Throughput Process Development (HTPD).
Paradigm Shift in Drug Discovery: Discover Small Molecule Degraders Using E3scan™ Technology Platform
ON-DEMAND By Eurofins Discovery
Book your place for our free webinar and learn about how targeted protein degradation (TPD) utilises small molecules to hijack the cellular degradation machinery through the recruitment of E3 ubiquitin ligases to proteins of interest.
The discovery and challenges of antibodies targeting GPCRs
ON-DEMAND By Domain Therapeutics
Watch our on-demand webinar which focused on the progress achieved in G protein-coupled receptor (GPCR) therapeutic antibody-based discovery and development.
